Review Article
BibTex RIS Cite

Year 2022, Volume: 8 Issue: 4, 344 - 358, 01.10.2022

Thi Sinh Vo , Tran Thi Bich Chau Vo , Tran Thi Thu Ngoc Vo

https://doi.org/10.3153/FH22032

Abstract

References

  • Acquas, E., Tanda, G., Di Chiara, G. (2002) Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pre-treated rats. Neuropsychopharmacology, 27(2), 182-193. https://doi.org/10.1016/S0893-133X(02)00290-7
  • Akash, M.S.H., Rehman, K., Li, N., Gao, J.-Q., Sun, H. , Chen, S. (2012). Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic po-tentials. Pharmaceutical Research, 29(12), 3475-3485. https://doi.org/10.1007/s11095-012-0843-0
  • Akash, M.S.H., Rehman, K., Sun, H.Y., Chen, S.Q. (2013). Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. European Journal of Pharmacology, 701(1-3), 87-95. https://doi.org/10.1016/j.ejphar.2013.01.008
  • Antonio, A.G., Moraes, R.S., Perrone, D., Maia, L.C., Santos, K.R.N., Iorio, N.L.P., Farah, A. (2010). Species, roasting degree and decaffeination influence the antibacterial activity of coffee against Streptococcus mutans. Food Chemistry, 118(3), 782-788. https://doi.org/10.1016/j.foodchem.2009.05.063
  • Arab, L., Khan, F., Lam, H. (2013). Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline. Advances in Nutrition, 4(1), 115-122. https://doi.org/10.3945/an.112.002717
  • Arendash, G.W., Mori, T., Cao, C.H., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B.A., Lin, X.Y., Echeverria, V., Potter, H. (2009). Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-beta Levels in Aged Alzheimer's Disease Mice. Journal of Alzheimers Disease, 17(3), 661-680. https://doi.org/10.3233/JAD-2009-1087
  • Bambha, K., Wilson, L.A., Unalp, A., Loomba, R., Neuschwander-Tetri, B.A., Brunt, E.M., Bass, N.M., Steatohepatitis, N. (2014). Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver International, 34(8), 1250-1258. https://doi.org/10.1111/liv.12379
  • Bata-Garcia, J.L., Tun-Coba, L., Alvarez-Cervera, F.J., Villanueva-Toledo, J.R., Heredia-Lopez, F.J., Gongora-Alfaro, J.L. (2010). Improvement of Postural Adjustment Steps in Hemiparkinsonian Rats Chronically Treated with Caffeine Is Mediated by Concurrent Blockade of a(1) and a(2a) Adenosine Receptors. Neuroscience, 166(2), 590-603. https://doi.org/10.1016/j.neuroscience.2009.12.072
  • Beghi, E., Pupillo, E., Messina, P., Giussani, G., Chio, A., Zoccolella, S., Moglia, C., Corbo, M., Logroscino, G., Grp, E. (2011). Coffee and Amyotrophic Lateral Sclerosis: A possible preventive role. American Journal of Epidemio-logy, 174(9), 1002-1008. https://doi.org/10.1093/aje/kwr229
  • Belaroussi, Y., Roblot, P., Peiffer-Smadja, N., Delaye, T., Mathoulin-Pelissier, S., Lemeux, J., Le Moal, G., Caumes, E., Roblot, F., Bleibtreu, A. (2020). Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? Journal of Clinical Medicine, 9(11). https://doi.org/10.3390/jcm9113691
  • Bhurwal, A., Rattan, P., Yoshitake, S., Pioppo, L., Reja, D., Dellatore, P., Rustgi, V. (2020). Inverse association of coffee with liver cancer development: An updated systematic review and meta-analysis. Journal of Gastrointestinal and Liver Diseases, 29(3), 421-428. https://doi.org/10.15403/jgld-805
  • Bohn, S.K., Blomhoff, R., Paur, I. (2014). Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Molecular Nutrition & Food Research, 58(5), 915-930. https://doi.org/10.1002/mnfr.201300526
  • Bosun-Arije, F.S., Ling, J., Graham, Y., Hayes, C. (2020). Organisational factors influencing non-pharmacological management of type 2 diabetes mellitus (T2DM) in public hospitals across Lagos, Nigeria: A qualitative study of nurses' perspectives. Diabetes Research and Clinical Practice 166. https://doi.org/10.1016/j.diabres.2020.108288
  • Bravi, F., Bosetti, C., Tavani, A., Gallus, S., La Vecchia, C. (2013). Coffee reduces risk for hepatocellular carcinoma: An updated meta-analysis. Clinical Gastroenterology and Hepatology, 11(11), 1413- 1421. https://doi.org/10.1016/j.cgh.2013.04.039
  • Campbell, B., Wilborn, C., La Bounty, P., Taylor, L., Nelson, M.T., Greenwood, M., Ziegenfuss, T.N., Lopez, H.L., Hoffman, J.R., Stout, J.R., Schmitz, S., Collins, R., Kalman, D.S., Antonio, J., Kreider, R.B. (2013). International society of sports nutrition position stand: energy drinks. Journal of the International Society of Sports Nutrition, 10. https://doi.org/10.1201/b16045
  • Canas, P.M., Porciuncula, L.O., Cunha, G.M.A., Silva, C.G., Machado, N.J., Oliveira, J.M.A., Oliveira, C.R., Cunha, R.A. (2009). Adenosine A(2A) receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 Mitogen-activated protein kinase pathway. Journal of Neuroscience, 29(47), 14741-14751. https://doi.org/10.1523/JNEUROSCI.3728-09.2009
  • Cao, C.H., Cirrito, J.R., Lin, X., Wang, L., Verges, D.K., Dickson, A., Mamcarz, M., Zhang, C., Mori, T., Arendash, G.W., Holtzman, D.M., Potter, H. (2009). Caffeine suppresses amyloid-beta levels in plasma and brain of alzheimer's disease transgenic mice. Journal of Alzheimers Disease, 17(3), 681-697. https://doi.org/10.3233/JAD-2009-1071
  • Carvalhana, S., Machado, M.V., Cortez-Pinto, H. (2012). Improving dietary patterns in patients with nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition and Metabolic Care, 15(5), 468-473. https://doi.org/10.1097/MCO.0b013e3283566614
  • Chen, S.H., Teoh, N.C., Chitturi, S., Farrell, G.C. (2014). Coffee and non-alcoholic fatty liver disease: Brewing evidence for hepatoprotection? Journal of Gastroenterology and Hepatology, 29(3), 435-441. https://doi.org/10.1111/jgh.12422
  • Chen, X.S., Ghribi, O., Geiger, J.D. (2010). Caffeine protects against disruptions of the blood-brain barrier in animal models of alzheimer's and parkinson's diseases. Journal of Alzheimers Disease, 20, S127-S141. https://doi.org/10.3233/JAD-2010-1376
  • Chen, X.S., Lan, X., Roche, I., Liu, R.G., Geiger, J.D. (2008). Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. Journal of Neurochemistry, 107(4), 1147-1157. https://doi.org/10.1111/j.1471-4159.2008.05697.x
  • Chu, Y.-F. (2012). Coffee: emerging health effects and disease prevention. p 352, John Wiley & Sons. ISBN: 0470958782, 9780470958780.
  • Ding, M., Bhupathiraju, S.N., Satija, A., van Dam, R.M., Hu, F.B. (2014). Long-term coffee consumption and risk of cardiovascular disease a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation, 129(6), 643-659. https://doi.org/10.1161/CIRCULATIONAHA.113.005925
  • Dostal, V., Roberts, C.M., Link, C.D. (2010). Genetic mechanisms of coffee extract protection in a caenorhabditis elegans model of beta-amyloid peptide toxicity. Genetics, 186(3), 857-U163. https://doi.org/10.1534/genetics.110.120436
  • Ejaz, N., Nisa, A., Akmal, J., Muhammad, A. (2004). Comparative study of physico-chemical parameters of different samples of non-branded tea. Pakistan Journal of Biochemistry and Molecular Biology, 37, 17-20.
  • Eskelinen, M.H., Kivipelto, M. (2010). Caffeine as a protective factor in dementia and alzheimer's disease. Journal of Alzheimers Disease, 20, S167-S174. https://doi.org/10.3233/JAD-2010-1404
  • Fang, C.Y., Cai, X.B., Hayashi, S., Hao, S.M., Sakiyama, H., Wang, X.J., Yang, Q., Akira, S., Nishiguchi, S., Fujiwara, N., Tsutsui, H., Sheng, J. (2019). Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids, 1864(3), 271-280. https://doi.org/10.1016/j.bbalip.2018.12.003
  • Farah, A., Monteiro, M.C., Calado, V., Franca, A.S., Trugo, L.C. (2006). Correlation between cup quality and chemical attributes of Brazilian coffee. Food chemistry 98(2), 373-380. https://doi.org/10.1016/j.foodchem.2005.07.032
  • Farkas, I.G., Czigner, A., Farkas, E., Dobo, E., Soos, K., Penke, B., Endresz, V., Mihaly, A. (2003). Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain. Acta Histochemica, 105(2), 115-125. https://doi.org/10.1078/0065-1281-00696
  • Ferlay, J. (2004) Cancer incidence, mortality and prevalence worldwide. GLOBOCAN2002.
  • Fisicaro, F., Lanza, G., Pennisi, M., Vagli, C., Cantone, M., Pennisi, G., Ferri, R., Bella, R. (2021). Moderate mocha coffee consumption is associated with higher cognitive and mood status in a non-demented elderly population with subcortical ischemic vascular disease. Nutrients, 13(2). https://doi.org/10.3390/nu13020536 Fisone, G., Borgkvist, A., Usiello, A. (2004). Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences, 61(7-8), 857-872. https://doi.org/10.1007/s00018-003-3269-3
  • Franceschi, S., Montella, M., Polesel, J., La Vecchia, C., Crispo, A., Dal Maso, L., Casarin, P., Izzo, F., Tommasi, L.G., Chemin, I. (2006). Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiology and Prevention Biomarkers, 15(4), 683-689. https://doi.org/10.1158/1055-9965.EPI-05-0702
  • Freedman, N.D., Curto, T.M., Lindsay, K.L., Wright, E.C., Sinha, R., Everhart, J.E., Grp, H.-C.T. (2011). Coffee Consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology, 140(7), 1961-1969. https://doi.org/10.1053/j.gastro.2011.02.061
  • Freedman, N.D., Everhart, J.E., Lindsay, K.L., Ghany, M.G., Curto, T.M., Shiffman, M.L., Lee, W.M., Lok, A.S., Di Bisceglie, A.M., Bonkovsky, H.L., Hoefs, J.C., Dienstag, J.L., Morishima, C., Abnet, C.C., Sinha, R., Grp, H.-C.T. (2009). Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology, 50(5), 1360-1369. https://doi.org/10.1002/hep.23162
  • Friedman, S.L., Neuschwander-Tetri, B.A., Rinella, M., Sanyal, A.J. (2018). Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine, 24(7), 908-922. https://doi.org/10.1038/s41591-018-0104-9
  • Godos, J., Micek, A., Marranzano, M., Salomone, F., Del Rio, D., Ray, S. (2017). Coffee consumption and risk of biliary tract cancers and liver cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients, 9(9). https://doi.org/10.3390/nu9090950
  • Gök, İ. (2021). Kavurma işlemi, demleme/pişirme yöntemlerinin kahvenin biyoaktif bileşenlerine etkisi: Fonksiyonel içecek olarak insan sağlığına faydaları. Food and Health, 7(4), 311-328. https://doi.org/10.3153/FH21032
  • Grosso, G., Godos, J., Galvano, F., Giovannucci, E.L. (2017). Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annual Review of Nutrition, Vol 37 37, 131-156. https://doi.org/10.1146/annurev-nutr-071816-064941
  • Hald, A., Lotharius, J. (2005). Oxidative stress and inflammation in Parkinson's disease: Is there a causal link? Experimental Neurology, 193(2), 279-290. https://doi.org/10.1016/j.expneurol.2005.01.013
  • Hameleers, P.A.H.M., Van Boxtel, M.P.J., Hogervorst, E., Riedel, W.J., Houx, P.J., Buntinx, F., Jolles, J. (2000). Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Human Psychopharmacology-Clinical and Experimental, 15(8), 573-581. https://doi.org/10.1002/hup.218
  • Helal, M.G., Ayoub, S.E., Elkashefand, W.F., Ibrahim, T.M. (2018). Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention. Human & Experimental Toxicology, 37(9), 983-990. https://doi.org/10.1177/0960327117747026
  • Higdon, J.V., Frei, B. (2006) Coffee and health: A review of recent human research. Critical Reviews in Food Science and Nutrition, 46(2), 101-123. https://doi.org/10.1080/10408390500400009
  • Hirakawa, N., Okauchi, R., Miura, Y., Yagasaki, K. (2005). Anti-invasive activity of niacin and trigonelline against cancer cells. Bioscience Biotechnology and Biochemistry, 69(3), 653-658. https://doi.org/10.1271/bbb.69.653
  • Hussain, S. Chowdhury, T.A. (2019) The impact of comorbidities on the pharmacological management of type 2 diabetes mellitus. Drugs, 79(3), 231-242. https://doi.org/10.1007/s40265-019-1061-4
  • Ikonomovic, M.D., Klunk, W.E., Abrahamson, E.E., Mathis, C.A., Price, J.C., Tsopelas, N.D., Lopresti, B.J., Ziolko, S., Bi, W.Z., Paljug, W.R., Debnath, M.L., Hope, C.E., Isanski, B.A., Hamilton, R.L., DeKosky, S.T. (2008). Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain, 131, 1630-1645. https://doi.org/10.1093/brain/awn016
  • Iwai, K., Kishimoto, N., Kakino, Y., Mochida, K., Fujita, T. (2004). In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. Journal of Agricultural and Food Chemistr, 52(15), 4893-4898. https://doi.org/10.1021/jf040048m
  • Jenner, P., Olanow, C.W. (2006). The pathogenesis of cell death in Parkinson's disease. Neurology, 66(10), S24-S36. https://doi.org/10.1212/WNL.66.10_suppl_4.S24
  • Johnson, S., Koh, W.P., Wang, R.W., Govindarajan, S., Yu, M.C., Yuan, J.M. (2011). Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes & Control, 22(3), 503-510. https://doi.org/10.1007/s10552-010-9725-0
  • Klockgether, T. (2004) Parkinson's disease: clinical aspects. Cell and Tissue Research, 318(1), 115-120. https://doi.org/10.1007/s00441-004-0975-6
  • Komorita, Y., Iwase, M., Fujii, H., Ohkuma, T., Ide, H., Jodai-Kitamura, T., Yoshinari, M., Oku, Y., Higashi, T., Nakamura, U., Kitazono, T. (2020) Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: The fukuoka diabetes registry. BMJ Open Diabetes Research & Care, 8(1). https://doi.org/10.1136/bmjdrc-2020-001252
  • Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Muller, C.E., Buee, L., Blum, D. (2014). Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiology of Aging, 35(9), 2079-2090. https://doi.org/10.1016/j.neurobiolaging.2014.03.027
  • Lloret, A., Fuchsberger, T., Giraldo, E., Vina, J. (2015). Molecular mechanisms linking amyloid beta toxicity and Tau hyperphosphorylation in Alzheimer's disease. Free Radical Biology and Medicine, 83, 186-191. https://doi.org/10.1016/j.freeradbiomed.2015.02.028
  • Llovet, J.M., Kelley, R.K., Villanueva, A., Singal, A.G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., Finn, R.S. (2021). Hepatocellular carcinoma. Nature Reviews Disease Primers, 6-6. https://doi.org/10.1038/s41572-020-00240-3
  • Loftfield, E., Rothwell, J.A., Sinha, R., Keski-Rahkonen, P., Robinot, N., Albanes, D., Weinstein, S.J., Derkach, A., Sampson, J., Scalbert, A., Freedman, N.D. (2020). Prospective Investigation of serum metabolites, coffee drinking, liver cancer incidence, and liver disease mortality. JNCI-Journal of the National Cancer Institute, 112(3), 286-294. https://doi.org/10.1093/jnci/djz122
  • Maughan, R.J., Griffin, J. (2003). Caffeine ingestion and fluid balance: a review. Journal of Human Nutrition and Dietetics, 16(6), 411-420. https://doi.org/10.1046/j.1365-277X.2003.00477.x
  • Mc Naughton, L.R., Lovell, R.J., Siegler, J.C., Midgley, A.W., Sandstrom, M., Bentley, D.J. (2008). The effects of caffeine ingestion on time trial cycling performance. Journal of Sports Medicine and Physical Fitness, 48(3), 320-325. https://doi.org/10.1123/ijspp.3.2.157
  • Modi, A.A., Feld, J.J., Park, Y., Kleiner, D.E., Everhart, J.E., Liang, T.J., Hoofnagle, J.H. (2010). Increased Caffeine consumption is associated with reduced hepatic fibrosis. Hepatology, 51(1), 201-209. https://doi.org/10.1002/hep.23279
  • Molloy, J.W., Calcagno, C.J., Williams, C.D., Jones, F.J., Torres, D.M., Harrison, S.A. (2012). Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology, 55(2), 429-436. https://doi.org/10.1002/hep.24731
  • Ngueta, G. (2020). Caffeine and caffeine metabolites in relation to hypertension in US adults. European Journal of Clinical Nutrition, 74(1), 77-86. https://doi.org/10.1038/s41430-019-0430-0
  • Ning, A., Cui, J., To, E., Ashe, K.H., Matsubara, J. (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Investigative Ophthalmology & Visual Science, 49(11), 5136-5143. https://doi.org/10.1167/iovs.08-1849
  • Pan, X.D., Zhu, Y.G., Lin, N., Zhang, J., Ye, Q.Y., Huang, H.P., Chen, X.C. (2011). Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease. Molecular Neurodegeneration, 6. https://doi.org/10.1186/1750-1326-6-45
  • Perumpail, B.J., Li, A.A., Iqbal, U., Sallam, S., Shah, N.D., Kwong, W., Cholankeril, G., Kim, D., Ahmed, A. (2018). Potential therapeutic benefits of herbs and supplements in patients with NAFLD. Diseases, 6(3), 80. https://doi.org/10.3390/diseases6030080
  • Pizzey, F.K., Tourula, E., Pearson, J. (2020). Tolerance to central hypovolemia is greater following caffeinated coffee consumption in habituated users. Frontiers in Physiology, 11. https://doi.org/10.3389/fphys.2020.00050
  • Poole, R., Kennedy, O.J., Roderick, P., Fallowfield, J.A., Hayes, P.C., Parkes, J. (2017). Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ-British Medical Journal, 359. https://doi.org/10.1136/bmj.j5024
  • Quan, H.Y., Kim, D.Y., Chung, S.H. (2013). Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells. BMB Reports, 46(4), 207-212. https://doi.org/10.5483/BMBRep.2013.46.4.153
  • Reitz, C., Mayeux, R. (2014). Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochemical Pharmacology, 88(4), 640-651. https://doi.org/10.1016/j.bcp.2013.12.024
  • Ritchie, K., Carriere, I., de Mendonca, A., Portet, F., Dartigues, J.F., Rouaud, O., Barberger-Gateau, P., Ancelin, M.L. (2007). The neuroprotective effects of caffeine - A prospective population study (the Three City Study). Neurology, 69(6), 536-545. https://doi.org/10.1212/01.wnl.0000266670.35219.0c
  • Rodrigues, F., Caldeira, D., Ferreira, J., Costa, J. (2015). Caffeine exposure and the risk of Parkinson's disease: an update of a systematic review and meta-analysis of observational studies. European Journal of Neurology, 22, 194-194.
  • Ruhl, C.E., Everhart, J.E. (2005). Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology, 129(6), 1928-1936. https://doi.org/10.1053/j.gastro.2005.08.056
  • Sang, L.X., Chang, B., Li, X.H., Jiang, M. (2013). Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterology, 13. https://doi.org/10.1186/1471-230X-13-34
  • Shimazu, T., Tsubono, Y., Kuriyama, S., Ohmori, K., Koizumi, Y., Nishino, Y., Shibuya, D., Tsuji, I. (2005). Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan. International Journal of Cancer, 116(1), 150-154. https://doi.org/10.1002/ijc.20989
  • Tavani, A., La Vecchia, C. (2004). Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Causes & Control, 15(8), 743-757. https://doi.org/10.1023/B:CACO.0000043415.28319.c1
  • Teramoto, M., Muraki, I., Yamagishi, K., Tamakoshi, A., Iso, H. (2021). Green Tea and coffee consumption and all-cause mortality among persons with and without stroke or myocardial infarction. Stroke, 52(3), 957-965. https://doi.org/10.1161/STROKEAHA.120.032273
  • Tohda, C., Kuboyama, T., Komatsu, K. (2005). Search for natural products related to regeneration of the neuronal network. Neurosignals, 14(1-2), 34-45. https://doi.org/10.1159/000085384
  • Torres, D.M., Harrison, S.A. (2013). Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology, 144(4), 670-672. https://doi.org/10.1053/j.gastro.2013.02.015
  • Trovato, G.M., Martines, G.F., Trovato, F.M., Catalano, D. (2013). Regular coffee: A magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD. Journal of Hepatology, 58(6), 1264-1265. https://doi.org/10.1016/j.jhep.2013.01.033
  • Tunnicliffe, J.M., Shearer, J. (2008). Coffee, glucose homeostasis, and insulin resistance: Physiological mechanisms and mediators. Applied Physiology Nutrition and Metabolism, 33(6), 1290-1300. https://doi.org/10.1139/H08-123
  • Tuomilehto, J., Hu, G., Bidel, S., Lindström, J., Jousilahti, P. (2004). Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA, 291(10), 1213-1219. https://doi.org/10.1001/jama.291.10.1213
  • Ullah, F., Ali, T., Ullah, N., Kim, M.O. (2015). Caffeine prevents D-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. Neurochemistry International, 90, 114-124. https://doi.org/10.1016/j.neuint.2015.07.001
  • Velázquez, A.M., Roglans, N., Bentanachs, R., Gené, M., Sala-Vila, A., Lázaro, I., Rodríguez-Morató, J., Sánchez, R.M., Laguna, J.C., Alegret, M. (2020). Effects of a low dose of caffeine alone or as part of a green coffee extract, in a rat dietary model of lean non-alcoholic fatty liver disease without inflammation. Nutrients, 12(11), 3240. https://doi.org/10.3390/nu12113240
  • Vitaglione, P., Morisco, F., Mazzone, G., Amoruso, D.C., Ribecco, M.T., Romano, A., Fogliano, V., Caporaso, N., D'Argenio, G. (2010). Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins. Hepatology, 52(5), 1652-1661. https://doi.org/10.1002/hep.23902
  • Vo, T.S., Vo, T.T.B.C., Vo, T.T.T.N. (2021a). Available chemical constituents and activities of ganoderma lucidum (lingzhi or red reishi) utilizing in disease treatment: A mini review. Journal of Research in Clinical Medicine, 9(1), 32-32. https://doi.org/10.34172/jrcm.2021.032
  • Vo, T.S., Vo, T.T.B.C., Vo, T.T.T.N. (2021b). A short review: Characterization and heath effects of saffron utilizing in disease treatment and prevention. Journal of Research in Clinical Medicine, 9(1), 28-28. https://doi.org/10.34172/jrcm.2021.028
  • Vo, T.S., Vo, T.T.B.C., Vo, T.T.T.N., Lai, T.N.H. (2021c) Turmeric (Curcuma longa L.): Chemical components and their effective clinical applications. Journal of the Turkish Chemical Society Section A: Chemistry, 8(3), 883-898. https://doi.org/10.18596/jotcsa.913136
  • Vo, T.S., Vo, T.T.T.N., Vo, T.T.B.C. (2020a). Coronavirus infection prevention by wearing masks. The Eurasian Journal of Medicine, 52(2), 197. https://doi.org/10.5152/eurasianjmed.2020.20056
  • Vo, T.S., Vo, T.T.T.N., Vo, T.T.B.C. (2020b). Handwashing in against of coronavirus disease 2019 infection. Journal of Research in Clinical Medicine, 8(1), 19-19. https://doi.org/10.34172/jrcm.2020.019
  • Watanabe, S., Takahashi, T., Ogawa, H., Uehara, H., Tsunematsu, T., Baba, H., Morimoto, Y., Tsuneyama, K. (2017). Daily Coffee intake inhibits pancreatic beta cell damage and nonalcoholic steatohepatitis in a mouse model of spontaneous metabolic syndrome, Tsumura-Suzuki obese diabetic mice. Metabolic Syndrome and Related Disorders, 15(4), 170-177. https://doi.org/10.1089/met.2016.011
  • Yanagimoto, K., Ochi, H., Lee, K.G., Shibamoto, T. (2004). Antioxidative activities of fractions obtained from brewed coffee. Journal of Agricultural and Food Chemistry, 52(3), 592-596. https://doi.org/10.1021/jf030317t
  • Yesil, A., Yilmaz, Y. (2013). Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 38(9), 1038-1044. https://doi.org/10.1111/apt.12489
  • Zelber-Sagi, S., Salomone, F., Webb, M., Lotan, R., Yeshua, H., Halpern, Z., Santo, E., Oren, R., Shibolet, O. (2015). Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Translational Research, 165(3), 428-436. https://doi.org/10.1016/j.trsl.2014.10.008
  • Zores, F., Rebeaud, M.E. (2020). COVID and the Renin-Angiotensin system: Are hypertension or its treatments deleterious? Frontiers in Cardiovascular Medicine, 7. https://doi.org/10.3389/fcvm.2020.00071

Coffee: Health effects and various disease treatments

Year 2022, Volume: 8 Issue: 4, 344 - 358, 01.10.2022

Thi Sinh Vo , Tran Thi Bich Chau Vo , Tran Thi Thu Ngoc Vo

https://doi.org/10.3153/FH22032

Abstract

To respond the growing demands for consuming natural foods, biochemical compounds originated from natural sources can be one of significant purposes for numerous researchers. In this review, we summarize the literatures regarding to the health effects of coffee consumption toward various human disease treatments, i.e., diabetes, cancer, liver diseases, and neurodegenerative diseases. The consumption of natural products is being common and considered significantly, for example, the potentially functional features of biochemical compounds contained in coffee have significantly contributed to clinical treatments of different human diseases. The experimental and epidemiologic evidences are indicated in this review to probably contribute to elucidate the protective effects of coffee consumption on several human diseases; besides, it is not still certain whether the consumption of coffee should be recommended to patients in some cases. Moreover, the chemical features and health benefits of coffee are introduced shortly, which can support readers understanding in detail to the benefits and the roles of coffee compounds.

Keywords

Coffee Disease treatment Diabetes Liver diseases Parkinson’s disease Alzheimer’s disease

References

  • Acquas, E., Tanda, G., Di Chiara, G. (2002) Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pre-treated rats. Neuropsychopharmacology, 27(2), 182-193. https://doi.org/10.1016/S0893-133X(02)00290-7
  • Akash, M.S.H., Rehman, K., Li, N., Gao, J.-Q., Sun, H. , Chen, S. (2012). Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic po-tentials. Pharmaceutical Research, 29(12), 3475-3485. https://doi.org/10.1007/s11095-012-0843-0
  • Akash, M.S.H., Rehman, K., Sun, H.Y., Chen, S.Q. (2013). Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. European Journal of Pharmacology, 701(1-3), 87-95. https://doi.org/10.1016/j.ejphar.2013.01.008
  • Antonio, A.G., Moraes, R.S., Perrone, D., Maia, L.C., Santos, K.R.N., Iorio, N.L.P., Farah, A. (2010). Species, roasting degree and decaffeination influence the antibacterial activity of coffee against Streptococcus mutans. Food Chemistry, 118(3), 782-788. https://doi.org/10.1016/j.foodchem.2009.05.063
  • Arab, L., Khan, F., Lam, H. (2013). Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline. Advances in Nutrition, 4(1), 115-122. https://doi.org/10.3945/an.112.002717
  • Arendash, G.W., Mori, T., Cao, C.H., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B.A., Lin, X.Y., Echeverria, V., Potter, H. (2009). Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-beta Levels in Aged Alzheimer's Disease Mice. Journal of Alzheimers Disease, 17(3), 661-680. https://doi.org/10.3233/JAD-2009-1087
  • Bambha, K., Wilson, L.A., Unalp, A., Loomba, R., Neuschwander-Tetri, B.A., Brunt, E.M., Bass, N.M., Steatohepatitis, N. (2014). Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver International, 34(8), 1250-1258. https://doi.org/10.1111/liv.12379
  • Bata-Garcia, J.L., Tun-Coba, L., Alvarez-Cervera, F.J., Villanueva-Toledo, J.R., Heredia-Lopez, F.J., Gongora-Alfaro, J.L. (2010). Improvement of Postural Adjustment Steps in Hemiparkinsonian Rats Chronically Treated with Caffeine Is Mediated by Concurrent Blockade of a(1) and a(2a) Adenosine Receptors. Neuroscience, 166(2), 590-603. https://doi.org/10.1016/j.neuroscience.2009.12.072
  • Beghi, E., Pupillo, E., Messina, P., Giussani, G., Chio, A., Zoccolella, S., Moglia, C., Corbo, M., Logroscino, G., Grp, E. (2011). Coffee and Amyotrophic Lateral Sclerosis: A possible preventive role. American Journal of Epidemio-logy, 174(9), 1002-1008. https://doi.org/10.1093/aje/kwr229
  • Belaroussi, Y., Roblot, P., Peiffer-Smadja, N., Delaye, T., Mathoulin-Pelissier, S., Lemeux, J., Le Moal, G., Caumes, E., Roblot, F., Bleibtreu, A. (2020). Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? Journal of Clinical Medicine, 9(11). https://doi.org/10.3390/jcm9113691
  • Bhurwal, A., Rattan, P., Yoshitake, S., Pioppo, L., Reja, D., Dellatore, P., Rustgi, V. (2020). Inverse association of coffee with liver cancer development: An updated systematic review and meta-analysis. Journal of Gastrointestinal and Liver Diseases, 29(3), 421-428. https://doi.org/10.15403/jgld-805
  • Bohn, S.K., Blomhoff, R., Paur, I. (2014). Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Molecular Nutrition & Food Research, 58(5), 915-930. https://doi.org/10.1002/mnfr.201300526
  • Bosun-Arije, F.S., Ling, J., Graham, Y., Hayes, C. (2020). Organisational factors influencing non-pharmacological management of type 2 diabetes mellitus (T2DM) in public hospitals across Lagos, Nigeria: A qualitative study of nurses' perspectives. Diabetes Research and Clinical Practice 166. https://doi.org/10.1016/j.diabres.2020.108288
  • Bravi, F., Bosetti, C., Tavani, A., Gallus, S., La Vecchia, C. (2013). Coffee reduces risk for hepatocellular carcinoma: An updated meta-analysis. Clinical Gastroenterology and Hepatology, 11(11), 1413- 1421. https://doi.org/10.1016/j.cgh.2013.04.039
  • Campbell, B., Wilborn, C., La Bounty, P., Taylor, L., Nelson, M.T., Greenwood, M., Ziegenfuss, T.N., Lopez, H.L., Hoffman, J.R., Stout, J.R., Schmitz, S., Collins, R., Kalman, D.S., Antonio, J., Kreider, R.B. (2013). International society of sports nutrition position stand: energy drinks. Journal of the International Society of Sports Nutrition, 10. https://doi.org/10.1201/b16045
  • Canas, P.M., Porciuncula, L.O., Cunha, G.M.A., Silva, C.G., Machado, N.J., Oliveira, J.M.A., Oliveira, C.R., Cunha, R.A. (2009). Adenosine A(2A) receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 Mitogen-activated protein kinase pathway. Journal of Neuroscience, 29(47), 14741-14751. https://doi.org/10.1523/JNEUROSCI.3728-09.2009
  • Cao, C.H., Cirrito, J.R., Lin, X., Wang, L., Verges, D.K., Dickson, A., Mamcarz, M., Zhang, C., Mori, T., Arendash, G.W., Holtzman, D.M., Potter, H. (2009). Caffeine suppresses amyloid-beta levels in plasma and brain of alzheimer's disease transgenic mice. Journal of Alzheimers Disease, 17(3), 681-697. https://doi.org/10.3233/JAD-2009-1071
  • Carvalhana, S., Machado, M.V., Cortez-Pinto, H. (2012). Improving dietary patterns in patients with nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition and Metabolic Care, 15(5), 468-473. https://doi.org/10.1097/MCO.0b013e3283566614
  • Chen, S.H., Teoh, N.C., Chitturi, S., Farrell, G.C. (2014). Coffee and non-alcoholic fatty liver disease: Brewing evidence for hepatoprotection? Journal of Gastroenterology and Hepatology, 29(3), 435-441. https://doi.org/10.1111/jgh.12422
  • Chen, X.S., Ghribi, O., Geiger, J.D. (2010). Caffeine protects against disruptions of the blood-brain barrier in animal models of alzheimer's and parkinson's diseases. Journal of Alzheimers Disease, 20, S127-S141. https://doi.org/10.3233/JAD-2010-1376
  • Chen, X.S., Lan, X., Roche, I., Liu, R.G., Geiger, J.D. (2008). Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. Journal of Neurochemistry, 107(4), 1147-1157. https://doi.org/10.1111/j.1471-4159.2008.05697.x
  • Chu, Y.-F. (2012). Coffee: emerging health effects and disease prevention. p 352, John Wiley & Sons. ISBN: 0470958782, 9780470958780.
  • Ding, M., Bhupathiraju, S.N., Satija, A., van Dam, R.M., Hu, F.B. (2014). Long-term coffee consumption and risk of cardiovascular disease a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation, 129(6), 643-659. https://doi.org/10.1161/CIRCULATIONAHA.113.005925
  • Dostal, V., Roberts, C.M., Link, C.D. (2010). Genetic mechanisms of coffee extract protection in a caenorhabditis elegans model of beta-amyloid peptide toxicity. Genetics, 186(3), 857-U163. https://doi.org/10.1534/genetics.110.120436
  • Ejaz, N., Nisa, A., Akmal, J., Muhammad, A. (2004). Comparative study of physico-chemical parameters of different samples of non-branded tea. Pakistan Journal of Biochemistry and Molecular Biology, 37, 17-20.
  • Eskelinen, M.H., Kivipelto, M. (2010). Caffeine as a protective factor in dementia and alzheimer's disease. Journal of Alzheimers Disease, 20, S167-S174. https://doi.org/10.3233/JAD-2010-1404
  • Fang, C.Y., Cai, X.B., Hayashi, S., Hao, S.M., Sakiyama, H., Wang, X.J., Yang, Q., Akira, S., Nishiguchi, S., Fujiwara, N., Tsutsui, H., Sheng, J. (2019). Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids, 1864(3), 271-280. https://doi.org/10.1016/j.bbalip.2018.12.003
  • Farah, A., Monteiro, M.C., Calado, V., Franca, A.S., Trugo, L.C. (2006). Correlation between cup quality and chemical attributes of Brazilian coffee. Food chemistry 98(2), 373-380. https://doi.org/10.1016/j.foodchem.2005.07.032
  • Farkas, I.G., Czigner, A., Farkas, E., Dobo, E., Soos, K., Penke, B., Endresz, V., Mihaly, A. (2003). Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain. Acta Histochemica, 105(2), 115-125. https://doi.org/10.1078/0065-1281-00696
  • Ferlay, J. (2004) Cancer incidence, mortality and prevalence worldwide. GLOBOCAN2002.
  • Fisicaro, F., Lanza, G., Pennisi, M., Vagli, C., Cantone, M., Pennisi, G., Ferri, R., Bella, R. (2021). Moderate mocha coffee consumption is associated with higher cognitive and mood status in a non-demented elderly population with subcortical ischemic vascular disease. Nutrients, 13(2). https://doi.org/10.3390/nu13020536 Fisone, G., Borgkvist, A., Usiello, A. (2004). Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences, 61(7-8), 857-872. https://doi.org/10.1007/s00018-003-3269-3
  • Franceschi, S., Montella, M., Polesel, J., La Vecchia, C., Crispo, A., Dal Maso, L., Casarin, P., Izzo, F., Tommasi, L.G., Chemin, I. (2006). Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiology and Prevention Biomarkers, 15(4), 683-689. https://doi.org/10.1158/1055-9965.EPI-05-0702
  • Freedman, N.D., Curto, T.M., Lindsay, K.L., Wright, E.C., Sinha, R., Everhart, J.E., Grp, H.-C.T. (2011). Coffee Consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology, 140(7), 1961-1969. https://doi.org/10.1053/j.gastro.2011.02.061
  • Freedman, N.D., Everhart, J.E., Lindsay, K.L., Ghany, M.G., Curto, T.M., Shiffman, M.L., Lee, W.M., Lok, A.S., Di Bisceglie, A.M., Bonkovsky, H.L., Hoefs, J.C., Dienstag, J.L., Morishima, C., Abnet, C.C., Sinha, R., Grp, H.-C.T. (2009). Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology, 50(5), 1360-1369. https://doi.org/10.1002/hep.23162
  • Friedman, S.L., Neuschwander-Tetri, B.A., Rinella, M., Sanyal, A.J. (2018). Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine, 24(7), 908-922. https://doi.org/10.1038/s41591-018-0104-9
  • Godos, J., Micek, A., Marranzano, M., Salomone, F., Del Rio, D., Ray, S. (2017). Coffee consumption and risk of biliary tract cancers and liver cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients, 9(9). https://doi.org/10.3390/nu9090950
  • Gök, İ. (2021). Kavurma işlemi, demleme/pişirme yöntemlerinin kahvenin biyoaktif bileşenlerine etkisi: Fonksiyonel içecek olarak insan sağlığına faydaları. Food and Health, 7(4), 311-328. https://doi.org/10.3153/FH21032
  • Grosso, G., Godos, J., Galvano, F., Giovannucci, E.L. (2017). Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annual Review of Nutrition, Vol 37 37, 131-156. https://doi.org/10.1146/annurev-nutr-071816-064941
  • Hald, A., Lotharius, J. (2005). Oxidative stress and inflammation in Parkinson's disease: Is there a causal link? Experimental Neurology, 193(2), 279-290. https://doi.org/10.1016/j.expneurol.2005.01.013
  • Hameleers, P.A.H.M., Van Boxtel, M.P.J., Hogervorst, E., Riedel, W.J., Houx, P.J., Buntinx, F., Jolles, J. (2000). Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Human Psychopharmacology-Clinical and Experimental, 15(8), 573-581. https://doi.org/10.1002/hup.218
  • Helal, M.G., Ayoub, S.E., Elkashefand, W.F., Ibrahim, T.M. (2018). Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention. Human & Experimental Toxicology, 37(9), 983-990. https://doi.org/10.1177/0960327117747026
  • Higdon, J.V., Frei, B. (2006) Coffee and health: A review of recent human research. Critical Reviews in Food Science and Nutrition, 46(2), 101-123. https://doi.org/10.1080/10408390500400009
  • Hirakawa, N., Okauchi, R., Miura, Y., Yagasaki, K. (2005). Anti-invasive activity of niacin and trigonelline against cancer cells. Bioscience Biotechnology and Biochemistry, 69(3), 653-658. https://doi.org/10.1271/bbb.69.653
  • Hussain, S. Chowdhury, T.A. (2019) The impact of comorbidities on the pharmacological management of type 2 diabetes mellitus. Drugs, 79(3), 231-242. https://doi.org/10.1007/s40265-019-1061-4
  • Ikonomovic, M.D., Klunk, W.E., Abrahamson, E.E., Mathis, C.A., Price, J.C., Tsopelas, N.D., Lopresti, B.J., Ziolko, S., Bi, W.Z., Paljug, W.R., Debnath, M.L., Hope, C.E., Isanski, B.A., Hamilton, R.L., DeKosky, S.T. (2008). Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain, 131, 1630-1645. https://doi.org/10.1093/brain/awn016
  • Iwai, K., Kishimoto, N., Kakino, Y., Mochida, K., Fujita, T. (2004). In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. Journal of Agricultural and Food Chemistr, 52(15), 4893-4898. https://doi.org/10.1021/jf040048m
  • Jenner, P., Olanow, C.W. (2006). The pathogenesis of cell death in Parkinson's disease. Neurology, 66(10), S24-S36. https://doi.org/10.1212/WNL.66.10_suppl_4.S24
  • Johnson, S., Koh, W.P., Wang, R.W., Govindarajan, S., Yu, M.C., Yuan, J.M. (2011). Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes & Control, 22(3), 503-510. https://doi.org/10.1007/s10552-010-9725-0
  • Klockgether, T. (2004) Parkinson's disease: clinical aspects. Cell and Tissue Research, 318(1), 115-120. https://doi.org/10.1007/s00441-004-0975-6
  • Komorita, Y., Iwase, M., Fujii, H., Ohkuma, T., Ide, H., Jodai-Kitamura, T., Yoshinari, M., Oku, Y., Higashi, T., Nakamura, U., Kitazono, T. (2020) Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: The fukuoka diabetes registry. BMJ Open Diabetes Research & Care, 8(1). https://doi.org/10.1136/bmjdrc-2020-001252
  • Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Muller, C.E., Buee, L., Blum, D. (2014). Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiology of Aging, 35(9), 2079-2090. https://doi.org/10.1016/j.neurobiolaging.2014.03.027
  • Lloret, A., Fuchsberger, T., Giraldo, E., Vina, J. (2015). Molecular mechanisms linking amyloid beta toxicity and Tau hyperphosphorylation in Alzheimer's disease. Free Radical Biology and Medicine, 83, 186-191. https://doi.org/10.1016/j.freeradbiomed.2015.02.028
  • Llovet, J.M., Kelley, R.K., Villanueva, A., Singal, A.G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., Finn, R.S. (2021). Hepatocellular carcinoma. Nature Reviews Disease Primers, 6-6. https://doi.org/10.1038/s41572-020-00240-3
  • Loftfield, E., Rothwell, J.A., Sinha, R., Keski-Rahkonen, P., Robinot, N., Albanes, D., Weinstein, S.J., Derkach, A., Sampson, J., Scalbert, A., Freedman, N.D. (2020). Prospective Investigation of serum metabolites, coffee drinking, liver cancer incidence, and liver disease mortality. JNCI-Journal of the National Cancer Institute, 112(3), 286-294. https://doi.org/10.1093/jnci/djz122
  • Maughan, R.J., Griffin, J. (2003). Caffeine ingestion and fluid balance: a review. Journal of Human Nutrition and Dietetics, 16(6), 411-420. https://doi.org/10.1046/j.1365-277X.2003.00477.x
  • Mc Naughton, L.R., Lovell, R.J., Siegler, J.C., Midgley, A.W., Sandstrom, M., Bentley, D.J. (2008). The effects of caffeine ingestion on time trial cycling performance. Journal of Sports Medicine and Physical Fitness, 48(3), 320-325. https://doi.org/10.1123/ijspp.3.2.157
  • Modi, A.A., Feld, J.J., Park, Y., Kleiner, D.E., Everhart, J.E., Liang, T.J., Hoofnagle, J.H. (2010). Increased Caffeine consumption is associated with reduced hepatic fibrosis. Hepatology, 51(1), 201-209. https://doi.org/10.1002/hep.23279
  • Molloy, J.W., Calcagno, C.J., Williams, C.D., Jones, F.J., Torres, D.M., Harrison, S.A. (2012). Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology, 55(2), 429-436. https://doi.org/10.1002/hep.24731
  • Ngueta, G. (2020). Caffeine and caffeine metabolites in relation to hypertension in US adults. European Journal of Clinical Nutrition, 74(1), 77-86. https://doi.org/10.1038/s41430-019-0430-0
  • Ning, A., Cui, J., To, E., Ashe, K.H., Matsubara, J. (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Investigative Ophthalmology & Visual Science, 49(11), 5136-5143. https://doi.org/10.1167/iovs.08-1849
  • Pan, X.D., Zhu, Y.G., Lin, N., Zhang, J., Ye, Q.Y., Huang, H.P., Chen, X.C. (2011). Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease. Molecular Neurodegeneration, 6. https://doi.org/10.1186/1750-1326-6-45
  • Perumpail, B.J., Li, A.A., Iqbal, U., Sallam, S., Shah, N.D., Kwong, W., Cholankeril, G., Kim, D., Ahmed, A. (2018). Potential therapeutic benefits of herbs and supplements in patients with NAFLD. Diseases, 6(3), 80. https://doi.org/10.3390/diseases6030080
  • Pizzey, F.K., Tourula, E., Pearson, J. (2020). Tolerance to central hypovolemia is greater following caffeinated coffee consumption in habituated users. Frontiers in Physiology, 11. https://doi.org/10.3389/fphys.2020.00050
  • Poole, R., Kennedy, O.J., Roderick, P., Fallowfield, J.A., Hayes, P.C., Parkes, J. (2017). Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ-British Medical Journal, 359. https://doi.org/10.1136/bmj.j5024
  • Quan, H.Y., Kim, D.Y., Chung, S.H. (2013). Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells. BMB Reports, 46(4), 207-212. https://doi.org/10.5483/BMBRep.2013.46.4.153
  • Reitz, C., Mayeux, R. (2014). Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochemical Pharmacology, 88(4), 640-651. https://doi.org/10.1016/j.bcp.2013.12.024
  • Ritchie, K., Carriere, I., de Mendonca, A., Portet, F., Dartigues, J.F., Rouaud, O., Barberger-Gateau, P., Ancelin, M.L. (2007). The neuroprotective effects of caffeine - A prospective population study (the Three City Study). Neurology, 69(6), 536-545. https://doi.org/10.1212/01.wnl.0000266670.35219.0c
  • Rodrigues, F., Caldeira, D., Ferreira, J., Costa, J. (2015). Caffeine exposure and the risk of Parkinson's disease: an update of a systematic review and meta-analysis of observational studies. European Journal of Neurology, 22, 194-194.
  • Ruhl, C.E., Everhart, J.E. (2005). Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology, 129(6), 1928-1936. https://doi.org/10.1053/j.gastro.2005.08.056
  • Sang, L.X., Chang, B., Li, X.H., Jiang, M. (2013). Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterology, 13. https://doi.org/10.1186/1471-230X-13-34
  • Shimazu, T., Tsubono, Y., Kuriyama, S., Ohmori, K., Koizumi, Y., Nishino, Y., Shibuya, D., Tsuji, I. (2005). Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan. International Journal of Cancer, 116(1), 150-154. https://doi.org/10.1002/ijc.20989
  • Tavani, A., La Vecchia, C. (2004). Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Causes & Control, 15(8), 743-757. https://doi.org/10.1023/B:CACO.0000043415.28319.c1
  • Teramoto, M., Muraki, I., Yamagishi, K., Tamakoshi, A., Iso, H. (2021). Green Tea and coffee consumption and all-cause mortality among persons with and without stroke or myocardial infarction. Stroke, 52(3), 957-965. https://doi.org/10.1161/STROKEAHA.120.032273
  • Tohda, C., Kuboyama, T., Komatsu, K. (2005). Search for natural products related to regeneration of the neuronal network. Neurosignals, 14(1-2), 34-45. https://doi.org/10.1159/000085384
  • Torres, D.M., Harrison, S.A. (2013). Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology, 144(4), 670-672. https://doi.org/10.1053/j.gastro.2013.02.015
  • Trovato, G.M., Martines, G.F., Trovato, F.M., Catalano, D. (2013). Regular coffee: A magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD. Journal of Hepatology, 58(6), 1264-1265. https://doi.org/10.1016/j.jhep.2013.01.033
  • Tunnicliffe, J.M., Shearer, J. (2008). Coffee, glucose homeostasis, and insulin resistance: Physiological mechanisms and mediators. Applied Physiology Nutrition and Metabolism, 33(6), 1290-1300. https://doi.org/10.1139/H08-123
  • Tuomilehto, J., Hu, G., Bidel, S., Lindström, J., Jousilahti, P. (2004). Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA, 291(10), 1213-1219. https://doi.org/10.1001/jama.291.10.1213
  • Ullah, F., Ali, T., Ullah, N., Kim, M.O. (2015). Caffeine prevents D-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. Neurochemistry International, 90, 114-124. https://doi.org/10.1016/j.neuint.2015.07.001
  • Velázquez, A.M., Roglans, N., Bentanachs, R., Gené, M., Sala-Vila, A., Lázaro, I., Rodríguez-Morató, J., Sánchez, R.M., Laguna, J.C., Alegret, M. (2020). Effects of a low dose of caffeine alone or as part of a green coffee extract, in a rat dietary model of lean non-alcoholic fatty liver disease without inflammation. Nutrients, 12(11), 3240. https://doi.org/10.3390/nu12113240
  • Vitaglione, P., Morisco, F., Mazzone, G., Amoruso, D.C., Ribecco, M.T., Romano, A., Fogliano, V., Caporaso, N., D'Argenio, G. (2010). Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins. Hepatology, 52(5), 1652-1661. https://doi.org/10.1002/hep.23902
  • Vo, T.S., Vo, T.T.B.C., Vo, T.T.T.N. (2021a). Available chemical constituents and activities of ganoderma lucidum (lingzhi or red reishi) utilizing in disease treatment: A mini review. Journal of Research in Clinical Medicine, 9(1), 32-32. https://doi.org/10.34172/jrcm.2021.032
  • Vo, T.S., Vo, T.T.B.C., Vo, T.T.T.N. (2021b). A short review: Characterization and heath effects of saffron utilizing in disease treatment and prevention. Journal of Research in Clinical Medicine, 9(1), 28-28. https://doi.org/10.34172/jrcm.2021.028
  • Vo, T.S., Vo, T.T.B.C., Vo, T.T.T.N., Lai, T.N.H. (2021c) Turmeric (Curcuma longa L.): Chemical components and their effective clinical applications. Journal of the Turkish Chemical Society Section A: Chemistry, 8(3), 883-898. https://doi.org/10.18596/jotcsa.913136
  • Vo, T.S., Vo, T.T.T.N., Vo, T.T.B.C. (2020a). Coronavirus infection prevention by wearing masks. The Eurasian Journal of Medicine, 52(2), 197. https://doi.org/10.5152/eurasianjmed.2020.20056
  • Vo, T.S., Vo, T.T.T.N., Vo, T.T.B.C. (2020b). Handwashing in against of coronavirus disease 2019 infection. Journal of Research in Clinical Medicine, 8(1), 19-19. https://doi.org/10.34172/jrcm.2020.019
  • Watanabe, S., Takahashi, T., Ogawa, H., Uehara, H., Tsunematsu, T., Baba, H., Morimoto, Y., Tsuneyama, K. (2017). Daily Coffee intake inhibits pancreatic beta cell damage and nonalcoholic steatohepatitis in a mouse model of spontaneous metabolic syndrome, Tsumura-Suzuki obese diabetic mice. Metabolic Syndrome and Related Disorders, 15(4), 170-177. https://doi.org/10.1089/met.2016.011
  • Yanagimoto, K., Ochi, H., Lee, K.G., Shibamoto, T. (2004). Antioxidative activities of fractions obtained from brewed coffee. Journal of Agricultural and Food Chemistry, 52(3), 592-596. https://doi.org/10.1021/jf030317t
  • Yesil, A., Yilmaz, Y. (2013). Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 38(9), 1038-1044. https://doi.org/10.1111/apt.12489
  • Zelber-Sagi, S., Salomone, F., Webb, M., Lotan, R., Yeshua, H., Halpern, Z., Santo, E., Oren, R., Shibolet, O. (2015). Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Translational Research, 165(3), 428-436. https://doi.org/10.1016/j.trsl.2014.10.008
  • Zores, F., Rebeaud, M.E. (2020). COVID and the Renin-Angiotensin system: Are hypertension or its treatments deleterious? Frontiers in Cardiovascular Medicine, 7. https://doi.org/10.3389/fcvm.2020.00071
There are 91 citations in total.

Details

Primary Language English
Subjects Structural Biology
Journal Section Review Articles
Authors

Thi Sinh Vo 0000-0003-3830-0474

Tran Thi Bich Chau Vo 0000-0002-3049-2080

Tran Thi Thu Ngoc Vo 0000-0001-9860-4678

Publication Date October 1, 2022
Submission Date March 12, 2022
Published in Issue Year 2022Volume: 8 Issue: 4

Cite

APA Vo, T. S., Vo, T. T. B. C., & Vo, T. T. T. N. (2022). Coffee: Health effects and various disease treatments. Food and Health, 8(4), 344-358. https://doi.org/10.3153/FH22032
 Download Cover Image

16339

Journal is licensed under a

CreativeCommons Attribtion-ShareAlike 4.0 International Licence  14627 1331027042
Diamond Open Access refers to a scholarly publication model in which journals and platforms do not charge fees to either authors or readers.

Open Access Statement:

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

Archiving Policy:

27222

Archiving is done according to ULAKBİM "DergiPark" publication policy (LOCKSS).